Evaluation of Anticardiolipin Antibodies and Lupus Erythematosus Cell in Type 2 Diabetes Nigerian Population

Authors

  • Odeyinka Odewusi Department of Medical Laboratory Science, College of Health and Medical Sciences, Afe Babalola University Ado-Ekiti, Ekiti State, Nigeria. https://orcid.org/0000-0001-9346-8101
  • Afanyi Abbey Department of Medical Laboratory Science, College of Health and Medical Sciences, Afe Babalola University Ado-Ekiti, Ekiti State, Nigeria.
  • Olalere Obadire Department of Medical Microbiology Federal Medical Centre, Birnin Kudu, Jigawa State, Nigeria
  • Olayinka Olaniyan Department of Medical Laboratory Science, College of Health and Medical Sciences, Adeleke University, Ede, Osun State, Nigeria.
  • Oluwadamilola Ogunyemi Department of Medical Laboratory Science, College of Health and Medical Sciences, Afe Babalola University Ado-Ekiti, Ekiti State, Nigeria
  • Emmanuel Omon Department of Medical Laboratory Science, College of Health and Medical Sciences, Afe Babalola University Ado-Ekiti, Ekiti State, Nigeria

Keywords:

Anticardiolipin Antibodies, Lupus Erythematosus Cell, Type 2 Diabetics, Hypertension.

Abstract

Background and aim. Diabetes mellitus, a chronic medical disorder characterized by persistent elevation blood glucose and, glycosuria together with its most common co morbidity still have so many mysteries that needs unravelling. This study was thus designed to evaluate serum anticardiolipin antibodies and the presence of lupus erythematosus cell in both treated and untreated uncomplicated and complicated type 2 diabetes. Methods. This study included 26 uncomplicated type 2 diabetes subjects, 15 were treated, 11 were untreated (newly diagnosed) and 31 complicated type 2 diabetes subjects, 17 were on treatment, 14 were untreated (newly diagnosed) and the remaining 17 were apparently healthy individuals which served as control. A total of 74 subjects were thus assessed. Determinations of blood pressure, Plasma glucose, BMI and anticardiolipin antibodies (ACA) was carried out on all subjects and the values seen in each of the groups compared with one another, however, this study also assessed the effect of treatment, gender and age on all estimated parameters. Results obtained were subjected to statistical analysis using Statistical Package for Social Sciences version 23 (SPSS 23). All parameters were expressed as mean ± SD, ANOVA was the tool of choice in comparing means and values were statistically significant at p<0.05. Results. Fasting blood glucose was significantly higher in treated and untreated uncomplicated and complicated type 2 diabetes with hypertension when compared to control respectively. In uncomplicated and complicated type 2 diabetes with hypertension, body mass index was significantly increased when treated and untreated were compared to control respectively. Lupus erythematosus test positivity of 5.8% and 7.1% were seen in treated complicated and untreated complicated diabetes respectively. Anticardiolipin antibody was also significantly higher in treated and untreated uncomplicated and complicated diabetics compared to control respectively. ACA was still higher in untreated compared to treated diabetics. Conclusion. This research found that ACA hence the likelihood of antiphospholipid syndrome is associated with type 2 diabetes mellitus. This can be more serious if there is vascular complication or when diabetes and its complications are poorly managed.

Downloads

Published

2023-04-25

How to Cite

1.
Odeyinka Odewusi, Afanyi Abbey, Olalere Obadire, Olayinka Olaniyan, Oluwadamilola Ogunyemi, Emmanuel Omon. Evaluation of Anticardiolipin Antibodies and Lupus Erythematosus Cell in Type 2 Diabetes Nigerian Population. Alq J Med App Sci [Internet]. 2023 Apr. 25 [cited 2024 Apr. 23];:201-1. Available from: https://journal.utripoli.edu.ly/index.php/Alqalam/article/view/237

Issue

Section

Articles

Similar Articles

1 2 3 4 5 6 7 > >> 

You may also start an advanced similarity search for this article.